Lyra Therapeutics, Inc. (LYRA) Net margin 2021–2025
Lyra Therapeutics, Inc. (LYRA) net profit margin by fiscal year — reported net income divided by reported revenue.
-7266.1%FY2025 · since FY2021: -15267.7% → -7266.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -7266.1% | -1175.1 pp |
| FY2024 | -6090.9% | -2067.8 pp |
| FY2023 | -4023.1% | +32.5 pp |
| FY2022 | -4055.6% | +11212.1 pp |
| FY2021 | -15267.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice